Article information
Abstract
Background
It is clinically important to detect and type human papillomavirus (HPV) in a sensitive and specific manner.
ObjectivesDevelopment of a nested-polymerase chain reaction-restriction fragment length polymorphism (nested-PCR-RFLP) assay to detect and type HPV based on the analysis of L1 gene.
MethodsAnalysis of published DNA sequence of mucosal HPV types to select sequences of new primers. Design of an original nested-PCR assay using the new primers pair selected and classical MY09/11 primers. HPV detection and typing in cervical samples using the nested-PCR-RFLP assay.
ResultsThe nested-PCR-RFLP assay detected and typed HPV in cervical samples. Of the total of 128 clinical samples submitted to simple PCR and nested-PCR for detection of HPV, 37 (28.9%) were positive for the virus by both methods and 25 samples were positive only by nested-PCR (67.5% increase in detection rate compared with single PCR). All HPV positive samples were effectively typed by RFLP assay.
ConclusionThe method of nested-PCR proved to be an effective diagnostic tool for HPV detection and typing.
Keywords:
DNA probes, HPV
polymerase chain reaction
polymorphism, restriction
fragment length
Full text is only aviable in PDF
References
[1.]
World Health Organization.
Human Papillomavirus and HPV Vaccines: Technical Information for Policy-makers and Health Professionals.
WHO, (2007),
[2.]
Ministério da Saúde 2009. Secretaria de Atenção à Saúde. Instituto Nacional de Câncer. Coordenação de Prevenção e Vigilância de Câncer. Estimativas 2010: Incidência de Câncer no Brasil. Rio de Janeiro: INCA. Available at: http://www.inca.gov.br/estimativa/2010/estimativa20091201.pdf. Accessed on Aug 2010.
[3.]
E.M. Burd.
Human papillomavirus and cervical cancer.
Clin Microbiol Rev, 16 (2009), pp. 1-17
[4.]
E.M. De Villiers, C. Fauquet, T.R. Broker, et al.
Classification of papillomaviruses.
Virology, 324 (2004), pp. 17-27
[5.]
M. Arbyn, P. Sasieni, C.J.L.M. Meijer, et al.
Chapter 9: Clinical applications of HPV testing: A summary of meta-analyses.
Vaccine, 24 (2006), pp. 78-89
[6.]
H.L. Smits, L.J. Bollen, S.P. Tjong-A-Hung, et al.
Intermethod variation in detection of human papilomavírus DNA in cervical smears.
J Clin Microbiol, 33 (1995), pp. 2631-2636
[7.]
J.U. Cope, A. Hildesheim, M.H. Schiffman, et al.
Comparison of the Hybrid Capture tube test and PCR for detection of human papillomavirus DNA in cervical specimens.
J Clin Microbiol, 35 (1997), pp. 262-265
[8.]
P.E. Castle, M. Schiffman, R.D. Burk, et al.
Restricted cross-reactivity of Hybrid Capture 2 with nononcogenic human papillomavirus types.
Cancer Epidemiol Biomarkers Prev, 11 (2002), pp. 1394-1399
[9.]
M. Poljak, I.J. Marin, K. Seme, et al.
Hybrid Capture II HPV test detects at least 15 human papillomavirus genotypes not included in its current high-risk probe cocktail.
J Clin Virol, 25 (2002), pp. 89-97
[10.]
A. Molijn, B. Kleter, W. Quint, et al.
Molecular diagnosis of human papillomavirus (HPV) infections.
J Clin Virol, 32 (2005), pp. 43-51
[11.]
R.A. Hubbard.
Human papillomavirus testing methods.
Arch Pathol Lab Med, 127 (2003), pp. 940-945
[12.]
P.E. Gravitt, F. Coutléeb, T. Iftnerc, et al.
New Technologies in Cervical Cancer Screening.
Vaccine, 26 (2008), pp. 42-52
[13.]
S. Pizzighella, M. Rassu, I. Piacentin, et al.
Polymerase chain reaction amplification and restriction enzyme typing as an accurate and simple way to detect and identify human papillomaviruses.
J Med Microbiol, 39 (1993), pp. 33-38
[15.]
T.A.A.M. Fernandes, R.V. Meissner, L.F. Bezerra, et al.
Human papillomavirus infection in women attended at a cervical cancer screening service in Natal Brazil.
Braz J Microbiol, 39 (2008), pp. 573-578
[16.]
S.A. Lippman, M.C.A. Sucupira, H.E. Jones, et al.
Prevalence, distribution and correlates of endocervical human papillomavirus types in Brazilian women.
Int J STD & AIDS, 21 (2010), pp. 105-109
[17.]
D. Wanderlei-Silva, M. Nobre, R.S. Gonzaga, et al.
High quality DNA from human papillomavirus (HPV) for PCR/RFLPs.
Braz Arch Biol Technol, 48 (2005), pp. 37-40
[18.]
S. Aedo, A. Melo, P. García, et al.
Detección y tipificación de vírus papiloma humano en lesiones preneoplásicas del cuello uterino mediante PCR-RFLP.
Rev Méd Chile, 135 (2007), pp. 167-173
[19.]
R.J. Nobre, L.P. Almeida, T.C. Martins.
Complete genotyping of mucosal human papillomavirus using a restriction fragment length polymorphism analysis and an original typing algorithm.
J Clin Virol, 42 (2008), pp. 13-21
[20.]
L.H.S. Oliveira, M.D.P.L. Ferreira, E.F. Augusto, et al.
Human papillomavirus genotypes in asymptomatic young women from public schools in Rio de Janeiro Brazil.
Rev Soc Bras Med Tropical, 43 (2010), pp. 4-8
[21.]
A. Chaiwongkot, C. Pientong, T. Ekalaksananan, et al.
evaluation of primers and PCR performance on HPV DNA screening in normal and low grade abnormal cervical cells.
Asian Pacific J Cancer Prevention, 8 (2007), pp. 279-282
[22.]
D.M. Winder, S.L.R. Ball, K. Vaughan, et al.
Sensitive HPV detection in oropharyngeal cancers.
BMC Cancer, 9 (2009), pp. 440-450
[23.]
S.H. Lee, V.S. Vigliotti, J.S. Vigliotti, S. Pappu.
Validation of human papillomavirus genotyping by signature DNA sequence analysis.
BMC Clin Pathol, 9 (2009), pp. 1-30
[24.]
R. Boom, C.J.A. Sol, M. Salimans, et al.
Rapid and simple method for purification of nucleic acids.
J Clin Microbiol, 28 (1990), pp. 495-503
[25.]
K. Sotlar, D. Diemer, A. Dethleffs.
Detection and typing of human papillomavirus by e6 nested multiplex PCR.
J Clin Microbiol, 42 (2004), pp. 3176-3184
[26.]
M.V. Jacobs, P.J.F. Snijders, F.J. Voorhorst, et al.
Reliable high risk HPV DNA testing by polymerase chain reaction: an intermethod and intramethod comparison.
J Clin Pathol, 52 (1999), pp. 498-503
[27.]
P.E. Gravitt, C.L. Peyton, T.Q. Alessi, et al.
Improved amplification of genital human papillomaviruses.
J Clin Microbiol, 38 (2000), pp. 357-361
[28.]
A.T. Hesselink, M.A.P.C. Van Ham, D.A.M. Heideman, et al.
Comparison of GP5/6- PCR and SPF10-Line blot assays for detection of high-risk human papillomavirus in samples from women with normal cytology results who develop grade 3 cervical intraepithelial neoplasia.
J Clin Microbiol, 46 (2008), pp. 3215-3221
[29.]
T.W. Remmerbach, U.G. Brinckmann, A. Hemprich, et al.
PCR detection of human papillomavirus of the mucosa: comparison between MY09/11 and GP5+/6+ primer sets.
J Clin Virol, 30 (2004), pp. 302-308
[30.]
L. Giovannelli, A. Lama, G. Capra, et al.
Detection of Human Papillomavirus DNA in Cervical Samples: Analysis of the New PGMY-PCR Compared To the Hybrid Capture II and MYPCR Assays and a Two-Step Nested-PCR Assay.
J Clin Microbiol, 42 (2004), pp. 3861-3864
[31.]
K. Husnjak, M. Grce, L. Magdic, et al.
Comparison of five different polymerase chain reaction methods for detection of human papillomavirus in cervical cell specimens.
J Virol Methods, 88 (2000), pp. 125-134
[32.]
A. Carrillo, A. Mohar, A. Meneses, et al.
Utilidad en la combinación de oligonucleótidos universales para la detección del vírus del papiloma humano en câncer cervicouterino y lesiones premalignas.
Salud Púb Méx, 46 (2004), pp. 7-15
Copyright © 2011. Elsevier Editora Ltda.. All rights reserved
